CSIMarket
 


Koninklijke Philips Nv  (PHG)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

PHG's Revenue Growth by Quarter and Year

Koninklijke Philips Nv's Revenue results by quarter and year




PHG Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 20,349.28 19,966.24 19,214.72 21,879.20
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   20,349.28 19,966.24 19,214.72 21,879.20



PHG Revenue fourth quarter 2023 Y/Y Growth Comment
Koninklijke Philips Nv achieved in the fourth quarter 2023, above Company average Revenue improvement of 1.92% year on year, to $ 20,349.28 millions.

Looking into fourth quarter 2023 results within Medical Laboratories industry 4 other companies have achieved higher Revenue growth. While Koninklijke Philips Nv' s Revenue increase of 1.92% ranks overall at the positon no. 493 in the fourth quarter 2023.




PHG Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 1.92 % 3.91 % -12.18 % 0.27 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   1.92 % 3.91 % -12.18 % 0.27 %

Financial Statements
Koninklijke Philips Nv's fourth quarter 2023 Revenue $ 20,349.28 millions PHG's Income Statement
Koninklijke Philips Nv's fourth quarter 2022 Revenue $ 19,966.24 millions Quarterly PHG's Income Statement
New: More PHG's historic Revenue Growth >>


PHG Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   1.92 % 3.91 % -12.18 % 0.27 %




Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #5
Healthcare Sector #57
Overall #493

Revenue Y/Y Growth Statistics
High Average Low
7.51 % 0.29 % -12.18 %
(Dec 31 2019)  
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #5
Healthcare Sector #57
Overall #493
Revenue Y/Y Growth Statistics
High Average Low
7.51 % 0.29 % -12.18 %
(Dec 31 2019)  

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Koninklijke Philips Nv's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PHG's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PHG's IV. Quarter Q/Q Revenue Comment


Koninklijke Philips Nv's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
0
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Dec 31 2020)
Cumulative Revenue 12 Months Ending $ 20,349.28 $ 19,966.24 $ 0.00 $ 19,214.72 $ 21,879.20
Y / Y Revenue Growth (TTM) 1.92 % 3.91 % - -12.18 % 0.27 %
Year on Year Revenue Growth Overall Ranking # 493 # 0 # 0 # 0 # 1436
Seqeuential Revenue Change (TTM) 1.92 % 3.91 % - -12.18 % 0.27 %
Seq. Revenue Growth (TTM) Overall Ranking # 502 # 0 # 0 # 0 # 1436




Cumulative Revenue growth Comment
Assuming the Koninklijke Philips Nv's fiscal year would have ended in Dec 31 2023, Koninklijke Philips Nv would have reprted above average annual Revenue improvement of 1.92% year on year, of $ 20,349 millions.
This marks a slow-down of the companys growth trends and from the 3.91% growth in Dec 31 2022.

In the Healthcare sector 56 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 493.

Revenue TTM Q/Q Growth Statistics
High Average Low
7.51 %
0.29 %
-12.18 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 5
Healthcare Sector # 57
Overall # 493

Revenue TTM Y/Y Growth Statistics
High Average Low
7.51 %
0.29 %
-12.18 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 58
S&P 500 # 502
Cumulative Revenue growth Comment
Assuming the Koninklijke Philips Nv's fiscal year would have ended in Dec 31 2023, Koninklijke Philips Nv would have reprted above average annual Revenue improvement of 1.92% year on year, of $ 20,349 millions.
This marks a slow-down of the companys growth trends and from the 3.91% growth in Dec 31 2022.

In the Healthcare sector 56 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 493.

Revenue TTM Q/Q Growth Statistics
High Average Low
7.51 %
0.29 %
-12.18 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 5
Healthcare Sector # 57
Overall # 493

Revenue TTM Y/Y Growth Statistics
High Average Low
7.51 %
0.29 %
-12.18 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 58
S&P 500 # 502




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PHG's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for PHG's Competitors
Revenue Growth for Koninklijke Philips Nv's Suppliers
Revenue Growth for PHG's Customers

You may also want to know
PHG's Annual Growth Rates PHG's Profitability Ratios PHG's Asset Turnover Ratio PHG's Dividend Growth
PHG's Roe PHG's Valuation Ratios PHG's Financial Strength Ratios PHG's Dividend Payout Ratio
PHG's Roa PHG's Inventory Turnover Ratio PHG's Growth Rates PHG's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Astrazeneca Plc3.29%$ 3.292 millions
West Pharmaceutical Services Inc 3.22%$ 3.217 millions
Becton Dickinson And Company2.62%$ 2.617 millions
Cumberland Pharmaceuticals Inc2.51%$ 2.514 millions
Prestige Consumer Healthcare Inc 2.33%$ 2.328 millions
Sanofi2.32%$ 2.324 millions
Amneal Pharmaceuticals Inc 2.30%$ 2.298 millions
Teleflex Incorporated2.09%$ 2.094 millions
Taro Pharmaceutical Industries Ltd2.07%$ 2.070 millions
Phibro Animal Health Corporation2.03%$ 2.032 millions
Icu Medical Inc1.94%$ 1.940 millions
Koninklijke Philips Nv1.92%$ 1.918 millions
Akebia Therapeutics Inc 1.84%$ 1.838 millions
Amedisys Inc 1.55%$ 1.552 millions
Abbott Laboratories1.49%$ 1.486 millions
Procyon Corporation1.36%$ 1.361 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com